Spandidos Publications style
Liu X, Wu Y, Zhou Z, Huang M, Deng W, Wang Y, Zhou X, Chen L, Li Y, Zeng T, Zeng T, et al: [Corrigendum] Celecoxib inhibits the epithelial‑to‑mesenchymal transition in bladder cancer via the miRNA‑145/TGFBR2/Smad3 axis. Int J Mol Med 52: 64, 2023.
APA
Liu, X., Wu, Y., Zhou, Z., Huang, M., Deng, W., Wang, Y. ... Fu, B. (2023). [Corrigendum] Celecoxib inhibits the epithelial‑to‑mesenchymal transition in bladder cancer via the miRNA‑145/TGFBR2/Smad3 axis. International Journal of Molecular Medicine, 52, 64. https://doi.org/10.3892/ijmm.2023.5267
MLA
Liu, X., Wu, Y., Zhou, Z., Huang, M., Deng, W., Wang, Y., Zhou, X., Chen, L., Li, Y., Zeng, T., Wang, G., Fu, B."[Corrigendum] Celecoxib inhibits the epithelial‑to‑mesenchymal transition in bladder cancer via the miRNA‑145/TGFBR2/Smad3 axis". International Journal of Molecular Medicine 52.2 (2023): 64.
Chicago
Liu, X., Wu, Y., Zhou, Z., Huang, M., Deng, W., Wang, Y., Zhou, X., Chen, L., Li, Y., Zeng, T., Wang, G., Fu, B."[Corrigendum] Celecoxib inhibits the epithelial‑to‑mesenchymal transition in bladder cancer via the miRNA‑145/TGFBR2/Smad3 axis". International Journal of Molecular Medicine 52, no. 2 (2023): 64. https://doi.org/10.3892/ijmm.2023.5267